The current status of clinical research on immune checkpoint inhibitors rechallenge in non-small cell lung cancer

ZHANG Chenyang, XU Meiling, CHEN Rongzheng, XING Pengfei, KONG Yuehong, ZHAO Xiangrong, ZHANG Junjun, ZHANG Liyuan

PDF(875 KB)
Tumor website：www.tumorsci.org E-mail Alert
PDF(875 KB)
Tumor ›› 2024, Vol. 44 ›› Issue (04) : 404-411. DOI: 10.3781/j.issn.1000-7431.2024.2402-0078
Review

The current status of clinical research on immune checkpoint inhibitors rechallenge in non-small cell lung cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 44(04): 404-411 https://doi.org/10.3781/j.issn.1000-7431.2024.2402-0078

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(875 KB)

Accesses

Citation

Detail
Sections
Recommended
Copyright © Tumor, All Rights Reserved.
E-mail: tumor@tumorsci.org
Powered by Beijing Magtech Co., Ltd.

/

〈 〉